Bank of America
JANX icon

Bank of America’s Janux Therapeutics JANX Stock Holding History

Bank of America’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
801,646
+63,316
+9% +$868K ﹤0.01% 2865
2025
Q4 		$10.2M Buy
738,330
+244,878
+50% +$5.76M ﹤0.01% 2839
2025
Q3 		$12.1M Sell
493,452
-365,971
-43% -$8.91M ﹤0.01% 3117
2025
Q2 		$19.9M Buy
859,423
+110,097
+15% +$2.9M ﹤0.01% 2558
2025
Q1 		$20.2M Sell
749,326
-45,435
-6% -$1.71M ﹤0.01% 2421
2024
Q4 		$42.6M Buy
794,761
+731,962
+1,166% +$38.7M ﹤0.01% 1638
2024
Q3 		$2.85M Sell
62,799
-56,596
-47% -$2.46M ﹤0.01% 4257
2024
Q2 		$5M Buy
119,395
+95,854
+407% +$4.5M ﹤0.01% 3619
2024
Q1 		$886K Sell
23,541
-20,260
-46% -$441K ﹤0.01% 4999
2023
Q4 		$470K Buy
43,801
+13,261
+43% +$115K ﹤0.01% 5541
2023
Q3 		$308K Buy
30,540
+9,393
+44% +$108K ﹤0.01% 5647
2023
Q2 		$251K Sell
21,147
-2,590
-11% -$34.6K ﹤0.01% 5692
2023
Q1 		$287K Buy
23,737
+5,239
+28% +$87.2K ﹤0.01% 5732
2022
Q4 		$244K Buy
18,498
+3,341
+22% +$48.9K ﹤0.01% 5808
2022
Q3 		$206K Sell
15,157
-10,361
-41% -$138K ﹤0.01% 5961
2022
Q2 		$312K Sell
25,518
-15,641
-38% -$185K ﹤0.01% 5765
2022
Q1 		$590K Buy
41,159
+33,525
+439% +$549K ﹤0.01% 5711
2021
Q4 		$150K Buy
7,634
+4,691
+159% +$98.3K ﹤0.01% 6658
2021
Q3 		$63K Buy
2,943
+895
+44% +$25.8K ﹤0.01% 6940
2021
Q2 		$52K Buy
+2,048
New +$45.6K ﹤0.01% 6817

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America's JANX Position: Q1 2026 in Review

Bank of America increased its Janux Therapeutics (JANX) stake by 8.6% in Q1 2026, buying an estimated $868K and bringing the position to 801,646 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2865.

Bank of America first reported a position in JANX in Q2 2021 and has held it in 20 quarters since. The position peaked at $42.6M in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Bank of America held 801,646 shares of Janux Therapeutics worth $11.1M as of Q1 2026.
  • Bank of America bought 63,316 Janux Therapeutics shares in Q1 2026, an estimated $868K.
  • Janux Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2865 holding.
  • Bank of America first reported a position in Janux Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Janux Therapeutics position peaked at $42.6M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.